Multidisciplinary

Top Medical News
5 hours ago
The oral antifungal drug VT-1161 (oteseconazole) is safe and effective in the treatment of women with acute vulvovaginal candidiasis (VVC), according to the results of a phase II study.
Pearl Toh, 9 hours ago
Consuming cranberry juice twice daily for 8 weeks can help suppress Helicobacter (H.) pylori infection among Chinese adults, suggests a randomized study — thus opening the door to using cranberry juice as a complementary approach to H. pylori management.
9 hours ago
High-frequency use of cannabis appears to worsen clinical pain and associated symptoms among chronic pain patients, a recent study has found.
11 hours ago
Frailty is a predictor of morbidity, mortality, and loss of independence in elderly patients needing emergency colorectal surgery, suggests a recent study.
12 hours ago
Use of bilateral prophylactic nipple-sparing mastectomy (NSM) appears to be safe in patients with high-risk breast cancer, a study has shown.
13 hours ago
Among doctors, men who suffer from personal burnout and women who have high levels of occupational stress have worse sexual function, a recent study has found.
14 hours ago
A phase I, single-centre, open-label study has found that repeated intravenous infusions of KHK4083, an investigational human monoclonal antibody, is sufficiently safe and clinically effective for the treatment of moderate to severe atopic dermatitis (AD).
Special Reports
Pearl Toh, 16 Sep 2020
Mepolizumab, a first-in-class anti-IL-5* antibody, effectively prevents asthma exacerbations in patients with severe eosinophilic asthma (SEA), according to a presentation at the ERS 2020 Congress.
16 Sep 2020
XOFLUZA – Baloxavir marboxil 20 mg and 40 mg FC tab
16 Sep 2020
OZEMPIC – Semaglutide 1.34 mg/mL soln for inj
16 Sep 2020
GALVUS MET – Vidagliptin, metformin HCl 50 mg/500 mg, 50 mg/850 mg and 50 mg/1,000 mg FC tab
16 Sep 2020
COSYREL – Bisoprolol fumarate, perindopril arginine 5 mg/5 mg, 5 mg/10 mg and 10 mg/10 mg FC tab
Dr. David Eichenbaum, Dr. Dilsher Dhoot, Prof. Peter Campochiaro, Dr. Timothy Y Y Lai, 04 Sep 2020

Intravitreal injection of antiangiogenic agents is the standard of care for neovascular age-related macular degeneration (nAMD), however, frequent injections represent a considerable treatment burden for patients. Results of the Ladder and Archway studies, presented at the 38th Annual Meeting of the American Society of Retina Specialists (ASRS 2020), showed that administration of ranibizumab through a port delivery system (PDS) considerably reduced treatment burden, while maintaining comparable efficacy and safety vs intravitreal injections. In an interview with MIMS Doctor, Dr Timothy Lai of Department of Ophthalmology & Visual Sciences, The Chinese University of Hong Kong, discusses how PDS may transform the management of nAMD.

Pank Jit Sin, 02 Sep 2020
The most recent report by the National Health and Morbidity Survey (NHMS) 2019 proved to be a blow to public health in Malaysia. Even with consistent, unrelenting efforts by stakeholders and policymakers, the figures for NCDs continue to climb. MIMS Doctor reached out to the Director-General of Health Tan Sri Dato' Seri Dr Noor Hisham Abdullah to get up to date with the COVID-19 situation in the country and to obtain his thoughts on the ramifications of the findings. 
Conference Reports
Roshini Claire Anthony, 18 Sep 2020

Adding selexipag to the double combination therapy of macitentan and tadalafil (triple combination) improved multiple outcomes in patients newly diagnosed with pulmonary arterial hypertension (PAH), results of the phase IIIb TRITON* trial showed.

Pearl Toh, 18 Sep 2020
Gefapixant, a first-in-class non-narcotic, oral P2X3 receptor antagonist, significantly reduces cough frequency in patients with refractory or unexplained chronic cough, according to two COUGH* studies presented at ERS 2020.
Stephen Padilla, 18 Sep 2020
A newly developed mobile wearable system promises to deliver accurate real-time assessment of respiratory pattern and thoracic motion noninvasively, according to a feasibility study in Japan.
Elaine Soliven, 18 Sep 2020
Adding mepolizumab to standard of care treatment significantly reduces nasal polyp size and obstruction in adults with chronic rhinosinusitis with nasal polyps (CRSwNP), according to the SYNAPSE* study presented at ERS 2020.
Audrey Abella, 17 Sep 2020
Patients with pulmonary arterial hypertension (PAH) experienced clinical improvement when they switched from a phosphodiesterase type 5 inhibitor (PDE-5i) to riociguat, highlighting the latter’s potential as a treatment alternative in this setting, results of the REPLACE* study have shown.
Pearl Toh, 16 Sep 2020
Mepolizumab, a first-in-class anti-IL-5* antibody, effectively prevents asthma exacerbations in patients with severe eosinophilic asthma (SEA), according to a presentation at the ERS 2020 Congress.
Audrey Abella, 16 Sep 2020
The final results of EVAPORATE* reinforce the plaque-regressing potential of icosapent ethyl (IPE) in patients on statins for elevated triglycerides.
CME Modules
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download